Financial Gravity Asset Management’s Emergent Biosolutions EBS Stock Holding History

Financial Gravity Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9	Closed	-$22	–	1517
2024 Q1	$22	Sell	9 -7	-44%	-$16	﹤0.01%	1110
2023 Q4	$39	Buy	+16	New	+$38	﹤0.01%	1166
2021 Q3	$50K	Hold	17	–	–	0.02%	569
2021 Q2	$63K	Buy	+17	New	+$1.09K	0.02%	489
2020 Q4	$9K	Buy	+106	New	+$9.73K	0.01%	186
2019 Q4	$54K	Sell	1,515 -746	-33%	-$40.5K	0.04%	600
2019 Q3	$118K	Sell	2,261 -504	-18%	-$23.5K	0.1%	182
2019 Q2	$134K	Sell	2,765 -593	-18%	-$28.4K	0.11%	194
2019 Q1	$169K	Buy	+3,358	New	+$198K	0.14%	153
2018 Q3	$192K	Sell	3,246 -148	-4%	-$8.64K	0.2%	127
2018 Q2	$187K	Sell	3,394 -325	-9%	-$16.9K	0.18%	137
2018 Q1	$190K	Buy	+3,719	New	+$185K	0.19%	104

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Financial Gravity Asset Management's EBS Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2024, closing a stake of 9 shares — an estimated $22 sold.

Financial Gravity Asset Management first reported a position in EBS in Q1 2018 and held it in 12 quarters. The position peaked at $192K in Q3 2018. 141 funds tracked by Wall St. Rank hold EBS as of Q2 2024.

Financial Gravity Asset Management reported no remaining Emergent Biosolutions position as of Q2 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 9 Emergent Biosolutions shares in Q2 2024, an estimated $22.
Financial Gravity Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 12 quarters.
Financial Gravity Asset Management's Emergent Biosolutions position peaked at $192K in Q3 2018.
141 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.